Doximity Review 2026

Doximity at a glance

Made by

Doximity, Inc., San Francisco, California, founded in 2010. It reports 3 million+ registered members, about 85% of US physicians. Doximity Q3 FY2026 results

Price

Ask, Scribe and Dialer are free. Doximity earns most of its revenue from pharmaceutical and health system advertising and expected about $643 million in fiscal 2026 revenue.

Who can use it

Verified US clinicians and medical students with a Doximity account. Doximity markets Ask to physicians and designs its products for US users.

What it does

Ask (formerly DoxGPT) gives cited answers in Instant or Thinking modes, drug information and drafted letters; Scribe drafts visit notes; Dialer handles calls and telehealth. Ask overview

Drug content

3,200+ drug monographs (vendor figure) from Pathway Medical, which Doximity bought for $63 million in 2025. CNBC, August 2025

Not included

Medical calculators, coding suggestions in Scribe (none described as of October 2026) and notes written directly into the EHR.

EHR integration

Scribe works separately from the EHR, so notes are copied and pasted, according to Doximity’s September 2026 guide. Doximity, September 2026

Usage

300,000+ unique clinicians used its AI tools in Q3 FY2026, and 150 health systems were on the Clinical AI Suite by June 2026 (vendor figures). Doximity, June 18, 2026

Patient data

Every user is covered by Doximity’s business associate agreement, accepted with its terms. Doximity says Scribe does not store or retain any audio. Doximity BAA

Who Doximity is for

What is Doximity Ask (formerly DoxGPT)?

Doximity Ask is the clinical AI assistant in Doximity’s app, renamed from DoxGPT in May 2026. It answers clinical questions with inline citations in Instant or Thinking modes, gives drug information from 3,200+ monographs (vendor figure), reads uploaded files and drafts appeal letters, prior authorizations and patient messages. Doximity describes these features; they have not been independently tested.

Doximity says citations link to full-text PDFs from more than 2,000 peer-reviewed journals (vendor figure), and its drug monographs, grounded in FDA labeling, cover dosing, interactions, contraindications and side effects. You can upload lab reports, imaging summaries, research PDFs or clinical notes, and save preferences for journals, charting formats and letter style.

The drug content came from Pathway Medical, which Doximity bought for $63 million in 2025 and folded into DoxGPT within seven weeks, so it is recent and still maturing. Ask sits in the Clinical AI Suite with Scribe and Dialer, introduced May 7, 2026, and the old doxgpt.com address now redirects to Doximity.

Is Doximity free?

Doximity is free for eligible US clinicians: Ask, Scribe and Dialer cost nothing on desktop and mobile. The company earns most of its revenue from pharmaceutical and health system advertising and expected about $643 million in revenue for fiscal 2026. Free access depends on a verified Doximity account, and its privacy policy says member data is used to target sponsored content.

Doximity has not yet commercialized its AI tools on their own, so their long-term business model is unproven; for now, advertising pays for the free suite.

Does Doximity have an AI scribe?

Doximity Scribe is a free ambient AI scribe for verified US physicians, nurse practitioners, physician assistants and medical students. It listens in the background during a visit and drafts SOAP notes, histories and physicals, consults, procedure summaries or dictations, with custom templates. Doximity says it does not store or retain any audio, and you copy the finished note into the EHR.

Doximity’s help center says Scribe records visits of up to 140 minutes, and the iOS app needs iOS 26 or later. Scribe launched in July 2025 with more than 10,000 beta users, and Doximity said in May 2026 that active users of its AI search and Scribe had tripled in nine months (vendor figures).

Unlike OpenEvidence Visits, Doximity Scribe did not describe ICD-10, E/M or CPT coding suggestions as of October 2026. Doximity’s terms put patient consent on the clinician: you must get consent from everyone whose conversation is transcribed.

How accurate is Doximity Ask?

Doximity Ask’s accuracy evidence comes from Doximity. In a company-published evaluation of more than 1,300 physicians, DoxGPT was preferred over OpenEvidence and other tools at more than twice the rate of the next option. In August 2026 Doximity’s CEO called Ask the top-performing US-based model in the NOHARM benchmark. Both are company statements, and the preference study was not independently peer reviewed.

PeerCheck, Doximity’s physician-led review program, has more than 10,000 medical experts and is co-chaired by Eric Topol and former US Surgeon General Regina Benjamin; PeerCheck-certified answers link to the reviewing physicians’ profiles. That adds human oversight but does not measure accuracy. Open the cited sources before an answer changes patient care, especially for drug dosing.

Does Doximity integrate with Epic and other EHRs?

Doximity’s AI tools run in its own app rather than inside the EHR. Doximity’s September 2026 guide says Scribe works separately from your EHR, so you copy and paste each note into the chart. Doximity has said Scribe will be built into Aledade Assist, an EHR overlay for Aledade’s practices, without naming a date.

Health systems can roll out the Clinical AI Suite to their clinicians: Doximity reported more than 100 health systems with enterprise access in early 2026 and 150 on the suite by June 18, 2026 (vendor figures). On October 20, 2026, Doximity and Wolters Kluwer announced that clinicians at health systems using both will see UpToDate-based answers in Ask.

Is Doximity Ask HIPAA compliant?

Doximity’s Ask page calls it “HIPAA-compliant and secure by default,” and every Doximity user is covered by the company’s business associate agreement, which takes effect when you accept its terms. That agreement lets Doximity commercialize de-identified data, including for product development. Check your organization’s policy before entering patient-identifying details.

Doximity says Scribe does not store or retain any audio, a statement repeated in its FY2026 annual report. Many hospitals restrict which AI tools can hear patient conversations or receive patient details, so confirm that Doximity is approved before using it with patients.

Strengths and limitations

Vera Health is the top-ranked tool in our 2026 clinical AI evaluation. Here’s how Doximity compares on price, documented features and our scores.

Showing all 20 criteria.Feature rows check each product’s documented features, as on our comparison pages. Scores are editorial judgments, not clinical benchmarks.

How Doximity compares

Doximity bundles free AI answers, a scribe and a dialer into an app many US physicians already use, but it has no calculators and is designed for US users. These are the products clinicians most often weigh against it.

What changed in 2026

1. October 20, 2026

   UpToDate answers are coming to Ask

   Doximity and Wolters Kluwer announced that clinicians at health systems using both products will see answers based on UpToDate content alongside Ask’s own answer “in the coming weeks.” Wolters Kluwer announcement

2. October 16, 2026

   Settled the OpenEvidence lawsuit

   Every party, including Doximity and Pathway Medical, signed a stipulation dismissing OpenEvidence’s 2025 lawsuit and Doximity’s counterclaims with prejudice. Each side pays its own legal fees; no other terms were disclosed, and no court ruled on either side’s allegations. The OpenEvidence–Doximity lawsuit and settlement

3. September 16, 2026

   A shareholder class action was filed

   A pension fund sued Doximity and several current and former executives, alleging the company overstated how much its Newsfeed drove revenue growth between August 2024 and May 2026. No court has decided the allegations, and the case is unrelated to OpenEvidence. CourtListener docket

4. August 6, 2026

   Company claims on Ask’s performance

   With its fiscal 2027 first-quarter results, Doximity’s CEO called Ask the top-performing US-based model in the NOHARM benchmark and reported AI search query growth of over 25% quarter over quarter. Both are company statements. Doximity results release

5. May 13, 2026

   A partnership with Aledade

   Doximity announced a partnership with Aledade and has said Scribe will be built into Aledade Assist, an EHR overlay for Aledade’s practices, without naming a date. Doximity announcement

6. May 7, 2026

   DoxGPT became Doximity Ask

   Doximity renamed DoxGPT to Ask and grouped it with Scribe and Dialer in its Clinical AI Suite. The old doxgpt.com address now redirects to Doximity. Doximity announcement

How Clinical AI Report rates Doximity

How this review was researched

Sources

13 sources, listed below, including Doximity’s product pages, business associate agreement and SEC filings, a Wolters Kluwer announcement, court records and news reports.

Evidence labels

Vendor claims are labelled as vendor figures. Independent studies and preprints are named, with their limits.

What was not tested

Clinical AI Report did not run its own accuracy test or measure time savings. The score is an editorial judgment against a published rubric, not a clinical benchmark.

Independence

Rankings are editorial opinions, not sponsored placements.

Read the scoring methodology, or send a correction.

Doximity FAQ